medigraphic.com
ISSN 0188-2198 (Impreso)

2000, Número 2

<< Anterior Siguiente >>

Rev Mex Cardiol 2000; 11 (2)


Choque cardiogénico

Lupi HE, Abundes VA, Martínez EA, Martínez GL, Martínez SC, Ramos CMA

Idioma: Español
Referencias bibliográficas: 89
Paginas: 254-269
Archivo PDF: 180.82 Kb.


RESUMEN

Definición

El choque cardiogénico es un síndrome que se presenta debido a la falla ventricular izquierda o derecha en forma aguda y grave, que produce hipotensión e hipoperfusión tisular con disfunción celular y multiorgánica progresiva. En la fase temprana, los mecanismos compensatorios pueden mantener un gasto cardiaco y perfusión sistémica marginal; sin embargo, si el proceso que condujo a la falla cardiaca persiste, se establece un círculo vicioso que finalmente conducirá a la disfunción miocárdica progresiva e irreversible.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Alpert JS, Becker RC. Cardiogenic shock: elements of etiology, diagnosis, and therapy. Clin Cardiol 1993; 16, 182-90.

  2. Scheidt S, Wilner G, Mueller H, Summers D, Lesch M, Wolff G et al. Intra-aortic balloon counterpulsation in cardiogenic shock. N Engl J Med 1973; 288: 979-984.

  3. Page DL, Cautfield JB, Kastor JA et al. Myocardial changes associated with cardiogenic shock. N Engl J Med 1971; 285: 133-37.

  4. Califf RM, Bengton JR. Cardiogenic shock. N Engl J Med 1994; 330: 172430.

  5. Hands ME, Rutherford JD, Muller JE, Davies G, Stone PH, Parker C et al. The in-hospital development of cardiogenic shock after myocardial infarction: incidence, predictors of ocurrence, outcome and prognostic factors. J Am Coll Cardiol 1989; 14: 40-6.

  6. Mueller HS. Role of intra-aortic counterpulsation in cardiogenic shock and myocardial infarction. Cardiology 1994; 84: 168-74.

  7. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley DJ et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 1999; 341: 625-34.

  8. Hochman JS, Boland J, Sleeper LA, Porway M, Brinker J, Col J et al. Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Circulation 1995; 91: 873-81.

  9. Bates ER, Stomel RJ, Hochman JS, Ohman EM. The use of intraaortic balloon counterpulsation as an adjunct to reperfusion therapy in cardiogenic shock. Int J of Cardiology 1998; (Suppl I): S37-42.

  10. Goldberg RJ, Gore JM, Alpert JS, Osganian V, De Groot J, Bade J et al. Cardiogenic shock after acute myocardial infarction. N Engl J Med 1991; 325: 1117-22.

  11. Holmes DR, Bates ER, Kleiman NS et al. Contemporary reperfusion therapy for cardiogenic shock: The GUSTO-I trial experience. J Am Coll Cardiol 1995; 26: 668-74.

  12. Muller JE, Rude RE, Braunwald E et al. Myocardial infarct extension: Ocurrence, outcome, and risk factors in the Multicenter Investigation of Limitacion of Infarct Size. Ann Intern Med 1988; 108: 1-6.

  13. Alonso DR, Scheidt S, Post M, Killip T. Pathophysiology of cardiogenic shock: Quantification of myocardial necrosis, clinical, pathological, and electrocardiographic correlations. Circulation 1973; 48: 588-96.

  14. Gewirtz H, Gold HK, Fallon JT, Pasternak RC, Leinbach RC. Role of right ventricular infarction in cardiogenic shock associated with inferior myocardial infarction. Br Heart J 1979; 42: 719-25.

  15. Gruppo Italiano per lo Studio della Streptochinas in ell’Infarto Miocardico (GISSI): Efectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 1: 397-401.

  16. Binder MJ, Ryan JA, Jr, Marcus S et al. Evaluation of therapy in shock following acute myocardial infarction. Am J Med 1955; 18: 622-32.

  17. Stomel RJ, Rasak M, Bates ER. Treatment strategies for acute myocardial infarction complicated by cardiogenic shock in a community hospital. Chest 1994;105: 997-1002.

  18. MillerLW. Mechanical assist devices in intensive cardiac care. Am Heart J 1991; 121: 1887-92.

  19. 19.-Ohman EM, Califf RM, George BS, Quigley PJ, Kereiakes DJ, Woodlief LH et al. The use of intra-aortic balloon pumping as an adjunct to reperfusion therapy in acute myocardial infarction. Am Heart J 1991; 121: 1895-901.

  20. Lee L, Bates ER, Pitt B, Walton JA, Laufer N, O’Neill WW. Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock. Circulation 1988; 78: 1345-51.

  21. Moosvi AR, Khaja F, Villanueva L et al. Early revascularization improves survival in cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol 1992; 19: 907-14.

  22. Hibbard MD, Holmes DR Jr, Bailey KR et al. Percutaneous transluminal coronary angioplasty in patients with cardiogenic shock. J Am Coll Cardiol 1992; 56: 815-21.

  23. Urban P, Stauffer JC, Bleed D et al. A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction: the (Swiss) multicenter trial of angioplasty for shock -(S)MASH. Eur Heart J 1999; 20: 1030-8.

  24. Petty TL. The Adult Respiratory Distress Syndrome (Confessions of a “Lumper”). Am Rev Respir Dis 1975; III: 713-5.

  25. Robin ED, Cross CE, Zelis R. Pulmonary edema (First of two parts) N Engl J Med 1978; 288(5): 239-45.

  26. Starling E. On the absorption of fluids from the connective tissue spaces. J Physiol (Lond) 1896; 19: 312-26,

  27. Guyton AL. Textbook of medical physiology. 7th ed. Philadelphia WB Saunders Company, 1986: 732.

  28. Staub NC. Pulmonary edema due to increase microvascular permeability to fluid and protein. Cir Res 1978; 43: 143.

  29. Damtzker. Cardiopulmonary critical care. 2th ed. Philadelphia WB Saunders Company 1991: 413.

  30. Staub NC, Nagano, Pearce ML. Pulmonary edema in dogs, specially the sequence of fluid accumulation in lungs. S Appl Physiol 1967; 22: 227.

  31. Brandwal E. Heart disease. A textbook of cardiovascular medicine. 4th Philadelphia WB Saunders Co. 1992: 554.

  32. Missal F. Cardiovascular drug therapy. Philadelphia WB Saunders Co. 1990: 26.

  33. Pinsky MR. Cardiopulmonary interactions: The effects of negative and positive changes in pleural pressure on cardiac output. In: Dantzker Cardiopulmonary Critical Care. 2th ed. Philadelphia WB Saunders Co. 1991: 87-120.

  34. Celis R, Kinney EL, Flaine SF, et al. Morphine: its use in pulmonary edema cardiovascular. Rev Rep 1981; 2: 257.

  35. Diksmit K, Vydem JK, Forrester JS, et al. Renal and extrarenal hemodynamics effects of furosemide in congestive heart failure after acute myocardial infarction. N Engl J Med 1973; 288: 1087.

  36. Killip, Kimball. Treatment of myocardial infarction in coronary care unit. Am J Cardiol 1967; 20: 457-64.

  37. Forrester JS. Diamond GA, Chatterjee K. Medical therapy of acute myocardial infarction by application of hemodynamic subjects. N Engl J Med 1976; 295: 1356.

  38. Norman JC, Cooley DA. Prognostic indices for survival during postcardiotomy intra-aortic ballon pumping. J Thorac Cardiovasc Surg 1977; 174: 709-20.

  39. Swan HJC, Ganz W, Forrester J, et al. Catheterization of the heart in man with the use of flow-directed ballon-tipped catheters. N Engl J Med 1970; 283: 447.

  40. Matthay MA, Chatterjee K. Bedside catheterization of pulmonary artery: Risk compared with benefits. Ann Intern Med 1988; 15: 826-34.

  41. Ryan, et al. Management of acute myocardial infarction. J Am Coll Cardiol 1996; 28: 1328-428.

  42. Rady MY. The role of central venous oximetry, lactic acid concentration and shock index in the evaluation of clinical shock: a review. Resuscitation 1992; 24: 55-60.

  43. Maccioli GA, Lucas WS, Norfleet EA. The intra-aortic balloon pump: A review. J of Cardiothoracic Anesthesia 1988; 2: 365-73.

  44. Goldenberg IF. Nonpharmacologic management of cardiac arrest and cardiogenic shock. Chest 1992; 102: 596(S): 596-615.

  45. Mueller HS. Role of intra-aortic counterpulsation in cardiogenic shock and acute myocardial infarction. Cardiology 1994; 84: 168-74.

  46. Park SB, Liebler G, Burkholder JA, Maher T et al. Mechanical support of the failing heart. Ann Thorac Surg 1986; 42: 627-31.

  47. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley D et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 1999; 341: 625-34.

  48. DeWood MA, Notske R, Hensley G, Shields JP, O’Grady, Spores J et al. Intra-aortic ballon counterpulsation with and without reperfusion for myocardial infarction shock. Circulation 1980; 61: 1105-1112.

  49. Dembitsky WP. Bridging from acute to chronic devices. Ann Thorac Surg 1999; 68; 724-8.

  50. Kern MJ, Aguirre FV, Tatineni S et al. Enhance coronary blood flow velocity during intra-aortic ballon counterpulsation in critically ill patients. J Am Coll Cardiol 1993; 21: 359-68.

  51. Scheidt S, Wilner G, Mueller H et al. Intra-aortic balloon counterpulsation in cardiogenic shock. N Engl J Med 1973; 288: 979-984.

  52. Bates ER, Stomel RJ, Hochman JS, Ohman M. The use of intraaortic balloon counterpulsation as an adjunct to reperfusion therapy in cardiogenic shock. Cardiology 1998; 65(Suppl I): 37-42.

  53. Ohman ME, George BS, White CJ et al. The use of intraaortic ballon pumping as an adjunct to reperfusion therapy in acute myocardial infarction. Am Heart J 1991; 121: 895-901.

  54. Ohman ME, George BS, White CJ et al. Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Circulation 1994; 90: 792-98.

  55. Grines CL. Aggresive intervention for myocardial infarction: angioplasty, stents, and intra-aortic ballon pumping. Am J Cardiol 1996; 78(Suppl 3A): 29-34.

  56. Ishihara M, Sato H, Tateishi H, Uchida T, Dote K, Intraaortic balloon pumping as the postangioplasty strategy in acute myocardial infarction. Am Heart J 1991; 122: 385-389.

  57. Hansen EC, Levine FH, Kay HR, Leinbach RC, Gold HK, Dagget WM et al. Control of postinfarction ventricular irritability with the intraaortic balloon pump. Circulation 1980; 62(Suppl I): I-130.

  58. Stone GW, Marsalece D, Brodie BR et al. A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. J Am Coll Cardiol 1997; 29: 1459-67.

  59. Anderson DR, Ohman HE, Holmes DR, Col J, Stebbins AL, Bates ER et al. Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I study. J Am Coll Cardiol 1997; 30: 708-15.

  60. Grotz RL, Yeston NS. Intraaortic balloon counterpulsation in high-risk cardiac patients undergoing non-cardiac surgery. Surgery 1989; 106(1): 1-5.

  61. Demas C, Flancbaum L, Scott G. The intra-aortic balloon pump as an adjuntive therapy for severe myocardial contusion. Am J Emerg Med 1987; 5(6): 499-502.

  62. Lane AS, Woodward AC, Goldman MR. Massive propranolol overdose poorly responsive to pharmacologic therapy: Use of the intra-aortic balloon pump. Ann Emerg Med 1987;16(12): 1381-1383.

  63. Cooley DA, Liotta D, Hollman GL, Bloodwell RD, Leachman RD, Milan JD. Orthotopic cardiac prosthesis for two staged cardiac replacement. Am J Cardiol 1969; 24: 723-30.

  64. Morales DL, Catanese KA, Helman DN, Williams Mr, Weinberg A, Goldstein DJ et al. Six-year experience of caring for forty-four patients with a left ventricular assist device at home: safe, economical, necessary. J Thorac Cardiovasc Surg 2000; 119: 251-9.

  65. Pennington DG, Oaks TE, Lohman DP. Permanent ventricular assist device support versus cardiac transplantation. Ann Thorac Surg 1999; 68: 729-33.

  66. Holman WL, Bourge RC, Spruell RD, Murrah P, McGiffin DC, Kirklin JK. Ventricular assist devices as a bridge to cardiac transplantation. Annals of Surgery 1997; 225: 695-706

  67. Park SB, Lieber GA, Burkholder JA, Maher TD, Benckart DH, Magovern GJ Jr et al. Mechanical support of the failing heart. Ann Thorac Surg 1986; 627-631.

  68. Guyton RA, Schonberger JP, Everts P, Jett K, Gray LA et al. Postcardiotomy shock: Clinical evaluation of the BVS 5000 Biventricular Support System. Ann Thorac Surg 1993; 56: 346-56.

  69. Park SJ, Nguyen DQ, Bank AJ, Ormaza S, Bolman M. Left ventricular assist device bridge therapy for acute myocardial infarction. Ann Thorac Surg 2000; 69: 1146-51.

  70. Chen JM, DeRoseII, Slater JP et al. Improved survival rates support left ventricular assist device implantation early after myocardial infarction. J Am Coll Cardiol 1999; 33: 1903-8.

  71. Houël E, Vermes E, Tixier DB, Le Besnerais P, Benhaiem-Sigaux N et al. Myocardial recovery after mechanical support for acute myocarditis: Is sustained recovery predictable? Ann Thorac Surg 1999; 68: 2177-80.

  72. Pasic M, Potapov E, Kuppe H, Hetzer R. Prolonged cardiopulmonary bypass for severe drug intoxication. J Thorac Cardiovasc Surg 2000; 119: 379-80.

  73. Chavanon O, Dutheil V, Hacini R, Borrel E, Tremel F, Blin D. Treatment of severe cardiac contusion with a left ventricular assist device in a patient with multiple trauma. J Thorac Cardiovasc Surg 1999; 118: 189-90.

  74. Frazier OH,Myers TJ. Left ventricular assist system as a bridge to myocardial recovery. Ann Thorac Surg 1999; 68: 734-41.

  75. Fukamachi K, McCarthy PM, Smedira NG, Vargo RL, Starling RC, Young JB. Preoperative risk factors for right ventricular assist device insertion. Ann Thorac Surg 199; 68:2181-4.

  76. Goldenberg IF. Nonpharmacologic management of cardiac arrest and cardiogenic shock. Chest 1992; 102: 597S-616S.

  77. Deng MC, Weyand M, Hammel D, Schmid C, Kerber S, Schmid C y col. Selection and outcome of ventricular assist device patients: The Muenster Experience. J Heart Lung Transplant 1998; 17: 817-25.

  78. Norman JC, Cooley DA, Igo SA et al. Prognostic indices for survival during postcardiotomy intra-aortic balloon pumping. J Thorac Cardiovasc Surg 1977; 74: 709-20.

  79. Curtis JJ, Walls JT, Wagner-Mann CC, Schmaltz RA, Demmy TL et al. Centrifugal pumps: description of devices and surgical techniques. Ann Thorac Surg 1999; 68: 666-71.

  80. Pagani FD, Lynch W, Swaniker F, Dyke DB, Bartlett R, Koelling T et al. Extracorporeal life support to left ventricular assist device bridge to heart transplant. Circulation 1999; 100(suppl II): II-206-II-210.

  81. Magovern GJ, Simpson KA. Extracorporeal membrane oxigenation for adult cardiac support: The Allegheny experience. Ann Thorac Surg 1999; 68: 655-61.

  82. Segesser LK. Cardiopulmonary support and extracorporeal membrane oxigenation for cardiac assist. Ann Thorac Surg 1999; 68: 672-7.

  83. DeRose JJ, Argenziano M, Sun B, Reemtsma K et al. Implantable left ventricular assist devices. Annals of Surgery 1997; 226: 461-70.

  84. Schmid C, Hammel D, Deng MC, Weyand M, Baba H, Tjan TDT et al. Ambulatory care of patients with left ventricular assist devices. Circulation 1999; 100(suppl II): II-224-II-228.

  85. Frazer OH, Rose EA, Macmanus Q, Burton NA, Lefrak EA, Poirier VL et al. Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device. Ann Thorac Surg 1992; 53: 1080-90.

  86. El-Banayosy A, Minami K, Arusoglu L, Fey O, Kizner L, Hartmann D. Long-term mechanical circulatory support. Thorac Cardiovasc Surgeon 1997; 45: 127-30.

  87. El-Banayosy A, Körfer R, Arusoglu L, Minami K, KiznerL, Fey O et al. Bridging to cardiac transplantation with the Thoratec ventricular assist device. Thorac Cardiovasc Surg 1999; 47 Suppl: 307-310.

  88. El-Banayosy A, Arusoglu L, Kizner L, Tenderich G, Minami K, Inoue K, Körfer R. Novacor left ventricular assistt system versus Heartmate vented electric left ventricular assist system as long-term mechanical circulatory support device in bridging patients: a prospective study. J Thorac Cardiovasc Surg 2000; 119: 581-7.

  89. Dembitsky WP. Bridging from acute to chronic devices. Ann Thorac Surg 1999; 68; 724-8.




2020     |     www.medigraphic.com